These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15934953)

  • 1. Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands.
    Matrisciano F; Scaccianoce S; Del Bianco P; Panaccione I; Canudas AM; Battaglia G; Riozzi B; Ngomba RT; Molinaro G; Tatarelli R; Melchiorri D; Nicoletti F
    J Neurochem; 2005 Jun; 93(5):1345-52. PubMed ID: 15934953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
    Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
    Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.
    Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G
    Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats.
    Matrisciano F; Caruso A; Orlando R; Marchiafava M; Bruno V; Battaglia G; Gruber SH; Melchiorri D; Tatarelli R; Girardi P; Mathè AA; Nicoletti F
    Neuropharmacology; 2008 Sep; 55(4):525-31. PubMed ID: 18590921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
    Galici R; Echemendia NG; Rodriguez AL; Conn PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?
    Matrisciano F; Panaccione I; Zusso M; Giusti P; Tatarelli R; Iacovelli L; Mathé AA; Gruber SH; Nicoletti F; Girardi P
    Mol Psychiatry; 2007 Aug; 12(8):704-6. PubMed ID: 17653204
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells.
    D'Onofrio M; Arcella A; Bruno V; Ngomba RT; Battaglia G; Lombari V; Ragona G; Calogero A; Nicoletti F
    J Neurochem; 2003 Mar; 84(6):1288-95. PubMed ID: 12614329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus.
    Matrisciano F; Storto M; Ngomba RT; Cappuccio I; Caricasole A; Scaccianoce S; Riozzi B; Melchiorri D; Nicoletti F
    Neuropharmacology; 2002 Jun; 42(8):1008-15. PubMed ID: 12128001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
    Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
    Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activation of mGlu2/3 metabotropic glutamate receptors protects retinal neurons against anoxic damage in the goldfish Carassius auratus.
    Beraudi A; Bruno V; Battaglia G; Biagioni F; Rampello L; Nicoletti F; Poli A
    Exp Eye Res; 2007 Mar; 84(3):544-52. PubMed ID: 17196590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.
    Ngomba RT; Biagioni F; Casciato S; Willems-van Bree E; Battaglia G; Bruno V; Nicoletti F; van Luijtelaar EL
    Neuropharmacology; 2005; 49 Suppl 1():89-103. PubMed ID: 16043198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG).
    Romei C; Raiteri M; Raiteri L
    Neuropharmacology; 2013 Mar; 66():311-6. PubMed ID: 22659408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.
    Orlando R; Borro M; Motolese M; Molinaro G; Scaccianoce S; Caruso A; di Nuzzo L; Caraci F; Matrisciano F; Pittaluga A; Mairesse J; Simmaco M; Nisticò R; Monn JA; Nicoletti F
    Neuropharmacology; 2014 Nov; 86():133-44. PubMed ID: 25063582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
    Lorrain DS; Schaffhauser H; Campbell UC; Baccei CS; Correa LD; Rowe B; Rodriguez DE; Anderson JJ; Varney MA; Pinkerton AB; Vernier JM; Bristow LJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1622-32. PubMed ID: 12825094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268.
    Sutton LP; Rushlow WJ
    J Neurochem; 2011 Jun; 117(6):973-83. PubMed ID: 21477044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
    Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
    J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment.
    Paul IA; Duncan GE; Powell KR; Mueller RA; Hong JS; Breese GR
    J Pharmacol Exp Ther; 1988 Sep; 246(3):956-62. PubMed ID: 2843636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.